Most medicines are designed to treat a variety of symptoms, but there is a new player in the field of medical treatment. disease medicine is designed to pinpoint the smallest of symptoms and focuses on thoroughly examining molecular and genomic information. The method is designed to find minute changes and patterns in particular cancers that may effect therapy outcomes. It is a type of research that can provide treatment options for cancer patients who aren't having success with traditional therapy.
Scientists believe that rare and resistant cancers are actually being prevented from being cured by using the current treatment options available. These limited treatment methods might actually harbor genomic changes that could otherwise be treated by specifically targeting them with a therapy routine. Thanks to a $10 million dollar donation and the combined efforts of the Cancer Institute of New Jersey and RUCDR, Infinite Biologics� within the Human Genetics Institute of New Jersey at Rutgers will be revamped. This will help specialists pinpoint the drivers that cause a tumor to be cancerous, and attack these cancerous cells with precision medicine and therapies that are more rapid than in the past.
Many people may ask the questions: what is precision medicine and how does it work?First, a tissue sample analysis is performed to assess the exact gene abnormalities causing the cancer. The analysis utilizes Next Generation Sequencing that focuses on more than 200 genes, by looking for different abnormalities. In doing this, scientists can learn how the targeted treatments will help prevent and treat different cancers. A medical oncologist is leading the precision medicine opportunity trial, and he shares that certain cancers are a complex group of cells with different responses to certain treatment strategies. Cancers that begin from an organ, such as the lung, are actually a group of diseases, and to properly care for each disease, many factors need to be taken into consideration for classification and treatment purposes.
Next Generation Sequencing is quicker and more efficient than previous methods, and it should take about a month see results. This allows researchers the chance to put their findings to good use quickly. There are weekly meetings of the precision medicine tumor board, to discuss biomarkers that have been recently identified. This board is composed of individuals with computational expertise, clinicians, basic scientists, and systems biologists. By working together they can quickly decide whether the results suggest new therapy methods, which may lead to the treatment's enrollment in a clinical trial.
The medical board is currently aiming for the development of clinical trials that focus on pinpointing specific genomic changes in a particular cancer. Quickly improving technology, faster results and a shifted focus can help pinpoint what exactly drives the growth in cancer cells and how to treat it. The new treatment solutions and precision meetings allow for trials to be completed quick and allow for potentially improved outcomes regarding patient's cancer treatments. What is precision medicine? It is something that could provide human beings with new insight into cancer and its treatment.